These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1173 related articles for article (PubMed ID: 25646366)

  • 1. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
    Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
    Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
    Wolin EM
    Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.
    Uprety D; Halfdanarson TR; Molina JR; Leventakos K
    Curr Treat Options Oncol; 2020 Aug; 21(11):86. PubMed ID: 32862320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The ectopic ACTH syndrome].
    Penezić Z; Savić S; Vujović S; Tatić S; Ercegovac M; Drezgićc M
    Srp Arh Celok Lek; 2004; 132(1-2):28-32. PubMed ID: 15227962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International trends in pulmonary neuroendocrine cancer studies:a scientometric study.
    Tanaka H; Del Giglio A
    Einstein (Sao Paulo); 2022; 20():eRW0113. PubMed ID: 36287436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bronchopulmonary carcinoid tumours].
    Rena O; Filosso PL; Ruffini E; Oliaro A
    Minerva Chir; 2002 Aug; 57(4):403-23. PubMed ID: 12145571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of
    Bongiovanni A; Recine F; Riva N; Foca F; Liverani C; Mercatali L; Nicolini S; Pieri F; Amadori D; Ibrahim T
    Clin Lung Cancer; 2017 Jul; 18(4):415-420. PubMed ID: 27956089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of typical and atypical lung carcinoids.
    Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
    Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update in pulmonary carcinoid tumors: a review article.
    Hage R; de la Rivière AB; Seldenrijk CA; van den Bosch JM
    Ann Surg Oncol; 2003 Jul; 10(6):697-704. PubMed ID: 12839856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary carcinoid tumors].
    Prosch H
    Radiologe; 2017 May; 57(5):397-406. PubMed ID: 28405692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.
    Baudin E; Hayes AR; Scoazec JY; Filosso PL; Lim E; Kaltsas G; Frilling A; Chen J; Kos-Kudła B; Gorbunova V; Wiedenmann B; Nieveen van Dijkum E; Ćwikła JB; Falkerby J; Valle JW; Kulke MH; Caplin ME; ;
    Neuroendocrinology; 2019; 108(1):7-17. PubMed ID: 30248673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapy for pulmonary carcinoids.
    Marquez-Medina D; Popat S
    Lung Cancer; 2015 Nov; 90(2):139-47. PubMed ID: 26371699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Diagnosis and Treatment of Bronchopulmonary Carcinoid.
    Kaifi JT; Kayser G; Ruf J; Passlick B
    Dtsch Arztebl Int; 2015 Jul; 112(27-28):479-85. PubMed ID: 26214234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations.
    Wolin EM
    Oncologist; 2015 Oct; 20(10):1123-31. PubMed ID: 26306904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multidisciplinary approach to the work up and management of pulmonary carcinoid tumors and DIPNECH: a narrative review.
    Ramirez RA; Cass AS; Das S; Low SW; Mehrad M; Rickman OB; Scherer PM; Thomas KE; Gillaspie EA
    Transl Lung Cancer Res; 2022 Dec; 11(12):2567-2587. PubMed ID: 36636417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in the Management of Typical and Atypical Lung Carcinoids.
    Prinzi N; Rossi RE; Proto C; Leuzzi G; Raimondi A; Torchio M; Milione M; Corti F; Colombo E; Prisciandaro M; Cascella T; Spreafico C; Beninato T; Coppa J; Lo Russo G; Di Bartolomeo M; de Braud F; Pusceddu S
    Clin Lung Cancer; 2021 May; 22(3):161-169. PubMed ID: 33618994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Typical and Atypical Carcinoids of the Lung: a Surgical Treatment Strategy].
    Kaifi JT; Schmid S; Passlick B
    Zentralbl Chir; 2016 Feb; 141(1):105-20. PubMed ID: 26902582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of neuroendocrine lung tumors.
    Sánchez de Cos Escuín J
    Arch Bronconeumol; 2014 Sep; 50(9):392-6. PubMed ID: 24685201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary carcinoid tumors.
    McMullan DM; Wood DE
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):289-300. PubMed ID: 12973707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.